3Shape Dx Software receives FDA 510(k) clearance
FDA clearance for 3Shape Dx Software now permits U.S. deployment. Relevant if you evaluate AI diagnostics for clinical integration.
3Shape has obtained FDA 510(k) Premarket Notification approval for its Dx Software, a dental AI platform designed to help dentists with oral diagnosis. The clearance, announced on April 28, 2026, permits the software to be commercially available and deployed in U.S. dental clinics.
What Dx Software does
Dx Software is a diagnostic aid that uses artificial intelligence to support dentists in identifying oral conditions. The platform integrates with 3Shape's existing ecosystem of imaging and clinical software, allowing dentists to incorporate AI-assisted diagnosis into their workflow without disrupting established practice systems.
FDA approval pathway and market availability
The 510(k) pathway allows dental software to demonstrate substantial equivalence to existing predicate devices rather than undergoing the more lengthy premarket approval process. This clearance enables 3Shape to market Dx Software immediately to U.S. dental practices and clinics. The software is designed to complement clinical judgment, not replace it, and follows FDA guidance for clinical decision support tools in dentistry.
Frequently asked questions
What is 3Shape Dx Software and what does it do?
Dx Software is a dental AI platform from 3Shape that aids dentists in the diagnosis of oral conditions. It integrates with 3Shape's existing imaging and clinical software to provide AI-assisted diagnostic support within the practice workflow.
When did 3Shape Dx Software receive FDA clearance?
3Shape announced FDA 510(k) Premarket Notification approval on April 28, 2026. This clearance permits the software to be commercially available in the United States immediately.
What is the FDA 510(k) pathway and why does it matter?
The 510(k) pathway allows medical devices and software to demonstrate substantial equivalence to existing predicate devices. It is faster than full premarket approval and is the standard pathway for diagnostic decision-support tools in dentistry.
Can U.S. dental practices use Dx Software now?
Yes. FDA 510(k) clearance permits immediate commercial availability. Dental clinics in the U.S. can now purchase and deploy Dx Software in their practices.
Does Dx Software replace clinical judgment?
No. Dx Software is designed as a diagnostic aid and clinical decision-support tool to complement, not replace, the dentist's clinical judgment and diagnosis.
